Analysis Life Sciences Thank You What We Expect the FDA to do in October 2023
Agency IQ
SEPTEMBER 29, 2023
That will have meant that FDA flagrantly missed its deadline to issue a guidance document related to medical countermeasure submissions and the use of Drug Master Files for platform technologies, which was due June 24, 2022. FDA is also due to revise 24 other guidance documents at that time. This is what OIRA is currently reviewing.
Let's personalize your content